Enveloped viruses rely on fusion proteins to mediate virus-cell membrane fusion during 31 cell entry (1). These same fusion proteins, when present in the plasma membrane of virus-32 infected cells, can induce cell-cell membrane fusion and syncytium formation. Studies of viral 33 fusogens have been instrumental in development of the fusion-through-hemifusion paradigm of 34 protein-mediated membrane fusion (2, 3). Initial formation of a hemifusion stalk structure from 35 merger of outer bilayer leaflets progresses to pore formation. These transitions are driven by 36 energy released during dramatic fusion protein conformational changes involving an extended 37 intermediate that converts to a folded-back, trimeric hairpin structure (4). In a poorly understood 38 process, subsequent expansion of these micropores generates the macropores needed for 39 syncytium formation. 40
The fusogenic ortho-and aquareoviruses are the only examples of non-enveloped viruses 41 that induce syncytium formation, and syncytium formation is a virulence determinant of these 42 viruses (5, 6). Each of these viruses encodes a fusion-associated small transmembrane (FAST) 43 protein that evolved specifically to induce cell-cell, rather than virus-cell, membrane fusion (7). 44
As dedicated cell-cell fusogens, the FAST proteins differ from enveloped virus fusogens both in 45 their primary biological function and structural features. The FAST proteins are the smallest 46 membrane fusion proteins, and with vestigial ectodomains of only ~20-40 residues (8-13) are 47 unlikely to mediate membrane fusion using the pathway envisioned for enveloped virus fusogens. 48
FAST protein-induced syncytium formation does not respond to compounds that alter 49 membrane curvature in a manner analogous to enveloped virus fusogens, consistent with the 50 concept that these different classes of viral fusogens differ in their mechanism of action. LPC is a 51 lysolipid with a large polar head group and a single hydrocarbon chain. When inserted into the 52 outer leaflet of a lipid bilayer, this inverted cone shape promotes positive curvature (i.e., the 53 monolayer bulges out toward the polar headgroups), the opposite curvature needed to form a 54 on July 13, 2017 by guest http://jvi.asm.org/ Downloaded from hemifusion stalk (14). However, lysophosphatidylcholine (LPC) effectively inhibits hemifusion 55 induced by numerous enveloped virus fusogens (15-19), but has no effect on pore formation 56 caused by the reptilian reovirus (RRV) p14 FAST protein (20). Here we report a novel, LPC-57 sensitive stage during virus mediated cell-to-cell fusion that follows the formation of stable 58 fusion pores. 59
In our previous study, cell-cell fusion was assessed using a dual fluorescence pore 60 formation assay (20) . In this assay, sparsely seeded donor QM5 cells co-transfected with RRV 61 formation as untreated cells (Fig. 1A) . Addition of LPC concurrent with addition of target cells 68 (t=0 in Fig. 1A ) inhibited or delayed pore formation by ~30%. While this might reflect a modest 69 direct inhibitory effect of LPC on p14-induced pore formation, we noted by microscopy that 70 target cells were slow to firmly attach to donor cells under these conditions. In contrast, LPC 71 inhibits pore formation induced by enveloped virus fusogens by >80% (20). Thus, unlike other 72 viral fusogens, p14-induced hemifusion and pore formation are relatively LPC-insensitive. 73
Interestingly, when cells were fixed, Giemsa stained and examined by light microscopy at 74 the end of the pore formation assay, we noted LPC almost completely inhibited p14-induced 75 syncytium formation (Fig. 1B) . These results were repeated in p14-transfected QM5 cell 76 monolayers, and syncytium formation was quantified by determining the average number of 77 syncytial nuclei present in five random microscopic fields of Giemsa-stained monolayers at 78 on July 13, 2017 by guest http://jvi.asm.org/ Downloaded from various times post-transfection. As shown in Fig. 2A , addition of LPC at 4 hpt essentially 79 abrogated syncytium formation; LPC therefore dramatically inhibits p14-induced 80 syncytiogenesis but not membrane fusion and pore formation, implying the expansion of stable 81 micropores into macropores is LPC-sensitive. As with LPC inhibited hemifusion induced by 82 enveloped virus fusogens (21) the block in p14-induced pore expansion was completely 83 reversible (Fig. 2B) . Furthermore, syncytiogenesis progressed at a markedly increased rate after 84 removal of LPC, reaching equivalent levels of syncytium formation as untreated cells within 30-85 45 min after LPC removal (Fig. 2B) . The increased rate of syncytiogenesis following release of 86 the LPC-mediated block to pore expansion suggests fusion pores continue to form in the 87 presence of LPC and are poised for expansion upon relief of the membrane curvature constraints 88 imposed by the lysolipid. 89
Using fluorescence microscopy to visualize content mixing in the absence of syncytium 90 formation, we confirmed LPC can "trap" fusion pores by inhibiting their expansion. At 4 hpt, 91 donor HT1080 cells co-transfected with RRV p14 and EGFP expression vectors were overseeded 92 with HT1080 target cells labeled with CellTrace calcein red-orange AM, 100µM myristoyl LPC 93 was added 1 h after co-culture, and cells were fixed at 12 hpt and visualized by fluorescence 94 microscopy. No dye transfer was observed in vector-transfected cells, while dual fluorescent 95 syncytia were apparent in p14-transfected cell monolayers in the absence of LPC (Fig. 3) . As 96 predicted, numerous mononucleated, dual fluorescent cell pairs were observed in p14-transfected 97 cell monolayers treated with LPC, but multinucleated syncytia were absent. These cell pairs 98 contained obvious intercellular connections, either between closely apposed cells or extending 99 considerable distances between cells (Fig. 3) . LPC therefore does not inhibit p14-induced cell-100 cell hemifusion or pore formation, but it does prevent pore expansion needed for syncytium 101 formation. 102 on July 13, 2017 by guest http://jvi.asm.org/
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To determine whether LPC can also arrest expansion of pores generated by enveloped 103 virus fusogens, influenza virus HA-mediated pore expansion and syncytium formation was 104 analyzed to define a post-pore formation, pre-syncytium formation interval for LPC addition. At 105 24 hpt, donor QM5 cells transfected with HA and EGFP expression vectors were overseeded 106 with target Vero cells labeled with calcein red. The donor and target cells were co-cultured for 4 107 h, and subsequently treated with 10µg/ml of trypsin for 3 min to effect cleavage activation of 108 HA0 to HA1 and HA2. Cells were then treated for 1 min with tissue culture medium buffered to 109 pH 4.8 to trigger conformational changes of the HA fusion complex necessary for mediating 110 membrane merger and pore formation. Flow cytometry analysis of soluble dye transfer between 111 donor and target cells revealed HA-mediated pore formation was detectable <5 min after 112 triggering fusion (Fig. 4A) , while syncytium formation was not evident until ~15 min post-pH 113 treatment (data not shown). LPC was therefore added 10 min after the pH trigger, when pore 114 formation was substantial (Fig. 4A ) but no visible syncytia were present (Fig. 4C) . Addition of 115 LPC at this time inhibited HA-mediated syncytium formation, as observed in Giemsa-stained 116 monolayers (Fig. 4B ) and by quantifying syncytial nuclei 2 h post-pH trigger (Fig. 4C) . As with 117 p14, LPC inhibition of HA-mediated syncytium formation was fully reversible, with syncytium 118 formation rapidly returning after removal of LPC to levels observed in untreated cell levels (Fig.  119   4C) . LPC is therefore a potent inhibitor of pore expansion and syncytium formation induced by 120 diverse viral fusogens. 121
Our results indicate that inhibiting negative membrane curvature in the outer membrane 122 leaflet generates a "stalled pore" phenotype that precedes syncytium formation induced by the 123 
